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Development/Plasticity/Repair
Congenital Cytomegalovirus Infection Alters Olfaction
Before Hearing Deterioration In Mice
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In developed countries, cytomegalovirus (CMV)-infected newborns are at high risk of developing sensorineural handicaps such as
hearing loss, requiring extensive follow-up. However, early prognostic tools for auditory damage in children are not yet available. In the
fetus, CMV infection leads to early olfactory bulb (OB) damage, suggesting that olfaction might represent a valuable prognosis for
neurological outcome of this viral infection. Here, we demonstrate that in utero CMV inoculation causes fetal infection and growth
retardation in mice of both sexes. It disrupts OB normal development, leading to disproportionate OB cell layers and rapid major
olfactory deficits. Olfaction is impaired as early as day 6 after birth in both sexes, long before the emergence of auditory deficits.
Olfactometry in males reveals a long-lasting alteration in olfactory perception and discrimination, particularly in binary mixtures of
monomolecular odorants. Although sensory inputs to the OB remain unchanged, hallmarks of autophagy are increased in the OB of
3-postnatalweek-oldmice, leading to local neuroinflammationand loss of neurons expressing tyrosinehydroxylase and calbindin.At the
cellular level, we found CMV-infected cells and an increased number of apoptotic cells scattered throughout the OB layers, whereas cell
proliferation in the neurogenic subventricular zone was decreased. These cellular observations were long-lasting, persisting up to 16
weeks after birth in both males and females and thus providing a mechanism supporting olfactory loss. Despite obvious differences in
neurogenesisbetweenhumanandmouse, these findingsoffernewstrategies aimedat earlydetectionofneurological dysfunctions caused
by congenital infections.
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Introduction
The high seroprevalence of herpes virus type-5 or cytomegalovi-
rus (CMV) constitutes a major public health concern due to pos-
sible sequelae in the fetus and newborn and the absence of
vaccines or curative treatments (Teissier et al., 2011; Manicklal et
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Significance Statement
In developed countries, congenital cytomegalovirus (CMV)-infected newborns are at high risk of developing sensory handicaps
such as hearing loss, thus requiring prolonged follow-up. In this study, we describe for the first time the functional impact of
congenital CMV infection on the olfactory system and its associated sense of smell. We demonstrate that a mouse model of
congenital CMV infection shows defects in olfactory bulb (OB) normal development and pronounced olfactory deficits affecting
acuity anddiscriminationof odorants. Thesemajor olfactory deficits occur longbefore the emergence of auditory deficits through
the upregulation of OB autophagy inducing local neuroinflammation and altered neuron content. Our findings provide new
opportunities for designing olfactory means to monitor the possible neurological outcome during congenital CMV infection.
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al., 2013). CMV is transmitted through bodily fluids, likely by the
oral and/or the intranasal route (Farrell et al., 2016; Jackson and
Sparer, 2018). Infection is usually asymptomatic or can have a
flu-type presentation except when transmitted from mother to
fetus. CMV belongs to the TORCH class of agents affecting the
fetal/neonatal brain that are transmitted in utero or intrapartum.
These agents include toxoplasmosis, rubella, herpes simplex and,
recently, Zika virus (Coyne and Lazear, 2016). In developed
countries, CMV infection is the leading cause of congenital mal-
formations. During pregnancy, CMV infects the placenta with
varied outcomes ranging from fetal growth retardation to irre-
versible birth defects, depending on maternal immunity and ges-
tational age (Pereira and Maidji, 2008; Fornara et al., 2017). Very
few prognostic tools for neurosensory sequelae have been devel-
oped; these include ultrasound examination for macroscopic
brain abnormalities and viral burden at birth (Forner et al.,
2015). Approximately 0.5–2% of newborns are CMV infected
and are at high risk of developing learning disabilities and hearing
loss, requiring prolonged follow-up care (Williamson et al., 1992;
Townsend et al., 2013).
CMV exhibits particular tropism for neural stem cells of the
olfactory system of fetuses (van Den Pol et al., 1999; Odeberg et
al., 2006; Teissier et al., 2014), thus lesioning the OB, but no study
has hitherto examined the impact of the virus on olfaction. Other
studies have reported olfactory deficits caused by neurotoxic and
viral lesions (Lazarini et al., 2012, 2014; Tian et al., 2016). Because
olfactory cues guide many behaviors, most importantly feeding
and social behaviors especially at early stages in life, it is plausible
that CMV induces behavioral changes resulting from olfactory
defects.
Olfaction is the first sensory modality to develop during fetal
life in mammals, long before vision and audition (Sarnat and Yu,
2016). Odor processing begins in olfactory sensory neurons
(OSNs) of the nasal epithelium, and then proceeds into the OB,
followed by primary olfactory cortex (Whitman and Greer,
2009). In humans, OSN olfactory receptors appear at gestational
8 weeks (W8; Bradley and Mistretta, 1975). OSNs are functional
in the fetus, as shown by evidence for antenatal learning of odors
and olfactory responses of preterm neonates (Engen and Lipsitt,
1965; Schaal et al., 1998, 2000). Olfactory reflexes constitute a
useful test in the neurological examination of the term neonates
(Sarnat, 1978). Indeed, the neural circuitry underlying the sense
of smell is established between the end of the second trimester of
pregnancy and early childhood, including a critical period iden-
tified in epidemiological studies (Kennedy et al., 2016). Axons
from OSNs project to the OB, where they form synapses on the
dendrites of mitral/tufted cells, the main projection neurons of
the OB, in organized structures called glomeruli. The OB consti-
tutes a usual entry portal for many neurotropic viruses, including
CMV, via anterograde transport along OSNs from the nasal epi-
thelium or OB capillaries (Monath et al., 1983; Winkler et al.,
2015; Farrell et al., 2016; Wheeler et al., 2017). Fetal OB infection
might cause irreversible neuron damage and thus immediate
olfactory deficits, preceding the delayed hearing loss that is
usually observed. For this reason, early detection of olfactory
impairment might represent a valuable prognostic tool for
these congenital infections.
To address the impact of CMV on olfaction, we investigated
olfactory behavior in an animal model of congenital CMV infec-
tion (Sakao-Suzuki et al., 2014). We show that virus-infected
mice display OB development abnormalities and pronounced
olfactory deficits long before the emergence of auditory deficits.
These findings provide the rationale for designing new olfactory
tests to monitor the possible neurological outcomes of these viral
infections.
Materials andMethods
Ethics statement. All animal procedures were performed in accordance
with French legislation and in compliance with the European Commu-
nities Council Directives (2010/63/UE, French Law 2013–118, February
6, 2013) according to the regulations of INSERM and Pasteur Institute
Animal Care Committees. The Animal Experimentation Ethics Commit-
tee (CETEA 89) of the Pasteur Institute approved this study (2015–
0028). Mice were housed in isolators and manipulated in class II safety
cabinets in the Pasteur Institute animal facilities accredited by the French
Ministry of Agriculture for performing experiments on live rodents.
CMV transplacental inoculation. Pups of timed Oncins France 1 (OF1)
pregnant mice from Charles Rivers Laboratory were intraplacentally in-
oculated under anesthesia (isoflurane) with 2 l of murine CMV (Smith
strain, ATCC VR-1399, at 10(4.75)TCID50/0.2 ml) or PBS at embryonic
day 13 (E13) as described previously (Sakao-Suzuki et al., 2014).
Design and groups. Following in utero intraplacental inoculation, mice
(total n  81) were divided in two groups, control (CTL) and CMV-
infected mice (CMV) for two separate experimental sets.
Experimental set 1. Experimental set 1 studied the impact of congenital
CMV infection on growth, olfaction, olfactory epithelium (OE), OB, and
subventricular zone (SVZ) of preweaning mice (see Figs. 1C, 2, 5). This
first set comprises a total of 56 inoculated mice (CTL: n 21, including
15 males; CMV: n  35, including 25 males). Olfaction was assessed 6
and 8 d after birth using 18 CTL and 19 CMV mice that were chosen
randomly (see Fig. 2). The body weight was assessed at day 8 after birth
for all the pups (see Fig. 1C). Immunohistochemistry and immunoblot
were performed at day 21 after birth using 10 mice per group (six animals
for immunohistochemistry and four animals for immunoblot) that were
chosen randomly (Fig. 5).
Experimental set 2. Experimental set 2 studied the impact of congenital
CMV infection on hearing, olfaction, OB, and SVZ of weaning mice (see
Figs. 1D,E, 3, 4, 6). This second set comprises a total of 25 inoculated
mice (CTL:n 13, including 11 males; CMV:n 12, including 8 males).
The presence of CMV nucleic acids was assessed by PCR in all the mice at
W3 in saliva samples. We chose to investigate hearing and olfactory
behavior in only male mice because the sample size for females was too
small to reach the needed power for statistical analysis. Hearing was
assessed in eight CMV male mice at W4 and W16 after birth and in eight
CTL male mice that were chosen randomly (see Fig. 1E). Olfactory tests
were conducted at W4 after birth using all the male mice (CTL: n 11;
CMV: n 8; see Figs. 3, 4). Following 1 week of training in olfactometers,
olfactory tests lasted 7 weeks (see Fig. 1A). Simple and difficult olfactory
discrimination (monomolecular odorants and odorant mixtures) was
assessed at W5–7 and W8 –9, respectively. Olfactory perception was as-
sessed at W10 –11. Buried food finding was performed at W12 on the
same mice. Olfactory memory was also assessed at W16. Immunohisto-
chemistry was performed at W16 after birth using 15 mice (CTL: n 7,
including 5 males; CM: n  8, including 4 males) that were chosen
randomly (see Fig. 6).
Data analysis and statistics. Data were analyzed using GraphPad Prism
software. Results are expressed as mean  SEM. The statistical test and
sample size (n) for each experiment are specified in the figure legends.
Sex ratio was compared between groups using Fisher’s exact test. Corre-
lation analysis was performed using nonparametric Spearman’s test. For
odorant discrimination tasks in olfactometers, data were analyzed by
two-way repeated-measures ANOVA. Other data were analyzed by
Gehan–Breslow–Wilcoxon, Mann–Whitney, or Wilcoxon matched-
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pairs signed-rank tests as appropriate. p  0.05 was considered
significant.
PCR analysis. To confirm the CMV infection, saliva samples were
collected at W3 and harvested for viral DNA extraction using a QIamp
DNA micro Kit (Qiagen). A set of oligonucleotide primers from the
murine CMV gene was selected on the DNA sequence designed by the
ATCC (GenBank accession number U68299). The base sequences coding
for UL73 for PCR were as follows: forward primer, 5-GAA-GGT-TCG-
TCG-TCG-TCG-AAG-3; and reverse primer, 5-TAG-CCG-TGT-
CTG-AGG-TGA-AGG-3. Template DNA was prepared by a series of
phenol– chloroform extractions (DNA mini kit, Qiagen) and 1 l of
sample DNA was added to the reaction mixture before amplification.
The final mixture using a PCR kit Qiagen was as follows: tampon 10
(2.5l), MgCl2 (1l), dNTP (1l), H2O (13.3l), Taq polymerase (0.2
l), forward primer (1 l), reverse primer (1 l), and template DNA (1
l). The DNA reaction mixture was then amplified as follows: step 1, 3
min at 94°C 1 cycle and step 2, 3 min at 94°C, 30 s at 60°C, 1.5 min at
72°C  35 cycles. The amplified DNA was electrophoresed on 1.0%
agarose gels, stained with ethidium bromide, and photographed.
Odorants. All nonsocial odorants were monomolecular compounds
from Sigma-Aldrich dissolved in water or mineral oil as indicated. Citral
has lemon scent; n-butanol has a rancid scent; D-limonene has an orange
scent; citronellal has a citronella scent; anethol has an anise scent; and
isoamylacetate has a banana scent.
Auditory brainstem responses (ABRs). Hearing loss was assessed using
ABR (OtoPhylab, RT Conception) as described previously (Nguyen et
al., 2009; Scimemi et al., 2014). Needle electrodes were placed subcuta-
neously under anesthesia with ketamine (40 mg/kg) and xylazine (4 mg/
kg). The reference electrodes were inserted beneath the pinna of the ears,
the ground beneath the skin of the neck, and the active electrode beneath
the skin of the back. Headphones with appropriate earplugs were used as
acoustic transducers. Clicks were delivered in range of 12–30 Hz. Filter
settings were at 150 –3000 Hz. Responses from 1000 sweeps were aver-
aged at each intensity level. Initially, the click intensity was reduced by 20
or 10 dB steps sound pressure level (SPL) and then by 5 dB SPL steps near
threshold. A contralateral auditory masking was used for high-intensity
stimulations (45 dB). The threshold was defined as the lowest intensity
at which a clear IV waveform was visible in the evoked trace and was
determined by visual inspection of the responses in blind of the mouse
group.
Recording and analysis of ultrasonic vocalizations. To assess olfaction in
6- to 8-d-old pups, we used custom-made olfactometers (Lemasson et al.,
2005) to measure the number of ultrasonic vocalizations emitted after
isolation as an index of odorant detection. The recording of ultrasonic
calls began 30 s after placing the pup in the custom-made chamber iso-
lator of olfactometers as described previously (Lemasson et al., 2005).
Ultrasonic vocalizations were detected using an ultrasonic microphone
connected to a bat detector (frequency range 10 –130 kHz, Magenta
BAT5 digital bat detector, RSPB) that converts ultrasonic sounds to the
audible frequency range. Using the broadband 60 kHz output of the
detector, ultrasonic calls were sampled, recorded, and analyzed using
Audacity open software (www.audacityteam.org). Ultrasonic emissions
were recorded during the 5 min isolation time of the pup into the olfac-
tometer during three successive test periods: the first period without any
odorant (1 min), the second period with exposure to social or nonsocial
odorant (1 min), and the last period with exhaust odorant (1 min and
30 s). The social odorant was a male scent from 10 g of soiled bedding
from a group of six unfamiliar male adult OF1 mice. The nonsocial
odorant was an odorant scent delivered from 10 ml of liquid 10% mineral
oil dilution of citral. After testing, pups were immediately put back with
their mothers. The mean rate of ultrasonic emissions (calls/min) was
computed for each time block.
Buried food-finding test. To assess olfaction in adult mice, we used the
buried food finding test after 20 h of food deprivation as described pre-
viously (Lazarini et al., 2012). Approximately 10 pieces of “Coco Pops”
cereal were hidden in the corner of the test cage under the bedding. The
mouse was placed in the opposite corner and the latency to find the food
within a 15 min period was recorded (defined as the time to locate cereals
and start digging). Thirteen minutes later, mice performed the same test
but with visible cereal positioned upon the bedding.
Olfactometry in weaning mice. Mice were partially water deprived by
receiving 1–2 ml/d of water for 1 week and then trained on a “go–no go”
discrimination task in computer-controlled olfactometers with custom-
made mouse chamber isolator. As described previously (Alonso et al.,
2012), mice were trained to respond to the presence of an odorant (pos-
itive stimulus, S) by licking the water delivery tube situated out of the
odorant sampling port (5 cm distance). They were also trained not to
respond on the presentation of another odorant or solvent (negative
stimulus, S	). A single stimulus (S or S	) was randomly presented at
each trial. Each series of 20 trials (block) comprised 10 presentations of
the rewarded odorant and 10 presentations of the nonrewarded odorant.
Licking response following an S trial and no licking following an S	
trial were scored as correct and called hit and correct rejection, respec-
tively. Approximately 10l of water were delivered as a reward in a hit. A
licking response following an S	 trial and no licking following an S
trial were scored as error and named false alarm and miss, respectively.
Accuracy (percentage of correct responses) was scored for each series of
20 trials [(hits correct rejections)/20 100]. Olfactory performances
were assessed using monomolecular odorant compounds and binary
odorant mixtures. Mice were given a session of 8 –10 series of 20 trials per
day. All odorants were diluted just before the experiments and their
concentrations are given as the dilution of the odorant in the saturator
bottles.
Odorant detection threshold. Mice were trained in olfactometers to
recognize n-butanol as the rewarded stimulus (S). Mice have to detect
successively descending decimal concentrations of n-butanol (S) di-
luted in water. In each session, water served as the S	. Mice were given
one to two sessions per day with one decimal dilution of the odorant per
session. The session ended at the criterion performance achievement
(75% of correct response in the series of 20 trials). If the criterion
performance was not achieved in two successive sessions with the same
odorant dilution, then the preceding dilution was considered as the de-
tection threshold.
Odorant discrimination tasks. Mice were trained to discriminate be-
tween: (1) D-limonene (dilution 10	2 in mineral oil, S) and citronellal
(dilution 10	2 in mineral oil, S) (simple discrimination task); (2)
D-limonene (dilution 10	2 in mineral oil, S) and anethol (dilution
10	2 in mineral oil S	) (simple discrimination task); and (3) 0.1%
isoamylacetate (dilution 10	3 in water, S) and anethol (S	) diluted in
mineral oil (simple discrimination task).
Then, olfactory discrimination performance was assessed for two iso-
amylacetate–anethol mixture tasks (difficult discrimination task). In the
first task, Swas a solution of 0.8% isoamylacetate and 0.2% anethol and
S	 was a solution of 0.2% isoamylacetate  and 0.8% anethole. In the
second task, Swas a solution of 0.6% isoamylacetate and 0.4% anethole
and S	 was a solution of 0.4% isoamylacetate and 0.6% anethol.
Long-termmemory test. Mice were given four daily training sessions of
eight blocks of 20 trials for D-limonene anethol discrimination task (S
was a solution of D-limonene at dilution 10 –2 in mineral oil and S	was
a solution of anethol dilution 10 –2 in mineral oil). Mice were then left for
30 d in their home cages and subjected to partial water deprivation for the
last 7 d. No water was given on day 29; the following day, each mouse was
subjected to a 20-trial memory test for the two odorant tasks. No rein-
forcement (reward) was given for correct responses in this session.
Immunohistochemistry, confocal imaging, and quantification. Mice
were anesthetized with sodium pentobarbital (100 mg/kg, i.p., Sanofi)
and perfused transcardially with a solution containing 0.9% NaCl and
heparin (5  10 3 U/ml, Sanofi) followed by 4% paraformaldehyde in
phosphate buffer. OE and brain were removed and postfixed by incuba-
tion in the same fixative overnight. OE were cryoprotected by incubation
in 30% sucrose in PBS overnight and then embedded in Tissue-tek
(Sakura). OE 20-m-thick transverse sections were obtained using a
cryostat (CM3050S, Leica) and were thaw-mounted onto coated glass
slides (Superfrost Plus). Forty-micrometer coronal brain sections were
obtained using a vibrating microtome (VT1000S, Leica). Immunostain-
ing was performed on free-floating sections for brain slices and fixed
sections for OE as described previously (Siopi et al., 2016). Sections were
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blocked in 0.2% Triton X-100, 4% bovine serum albumin (BSA, Sigma-
Aldrich), and 2% goat serum and incubated overnight with primary
antibodies at 4°C followed by an incubation step with secondary antibod-
ies (biotinylated or Alexa Fluor-conjugated secondary antibodies, Jack-
son ImmunoResearch Laboratories) at room temperature. The primary
antibodies used in this study and their working dilutions are listed in
Table 1. For immunolabeling of either murine CMV (Cekinovic´ et al.,
2008), tyrosine hydroxylase (TH), anti-ionized calcium binding adaptor
molecule (Iba1), and cluster of differentiation (CD) 68, brain sections
were preincubated for 20 min in citrate buffer 0.1 M, pH 9.0, at 80°C.
Fluorescent sections were stained with the nuclear dye 4,6-diamidino-
2-phenylindole (DAPI) and then mounted in Fluoromount solution
(eBiosciences). Immunoperoxidase-labeled cells were developed using
the ABC system (Vector Laboratories) and 3,3-diaminobenzidine
(0.05%, Sigma-Aldrich) as chromogen and then sections were mounted
in Depex medium.
For cell counting, six OE consecutive slices from the posterior nasal
cavity and four to eight brain slices separated by120m were selected for
each animal. Whole OE, OB, or SVZ mosaics were obtained using an
Olympus BX51 microscope (20 objective) and Compix imaging soft-
ware (Hamamatsu Photonics) for the analysis of immunoperoxidase-
labeled cells or the spinning disk confocal microscope Cell Voyager
(CV1000, Yokogawa) for the analysis of immunofluorescent-labeled
cells. The borders of the OE septum, SVZ, rostral migratory stream
(RMS), glomerular layer (GL), and granule cell layer (GCL) were delin-
eated blinded to the results. The glomerulus area was assessed by mea-
suring the area occupied by olfactory marker protein (OMP). The
thickness of the OE was measured on each side of the dorsal septum as the
total distance between the basement membrane and the top of the ciliary
layer in 0.1% cresyl violet solution (Nordic BioSite)-stained sections.
Positive cells were automatically counted using the “spot detector” tool
of the Icy open source platform (de Chaumont et al., 2012). For the
quantification of OSN-positive cells in the OE, six or seven zones be-
tween the basement membrane and the top of the ciliary layer were
analyzed per section of the olfactory mucosa situated in the dorsal sep-
tum of the posterior nasal cavity zones.
Protein blotting and quantification. OBs were dissected, snap frozen in
liquid nitrogen, and lysed in RIPA lysis buffer (25 mM Tris-HCl, pH 7.6,
150 mM NaCl, 1% NP-40, 1% sodium deoxycholate, 0.1% SDS) (Pierce/
Thermo Scientific), Protease Complete (Roche), and phosphatase
(phosSTOP, Roche) inhibitors. Protein concentration was measured
with Pierce BCA protein Assay Kit. Tissue lysates were mixed with 4
NuPage LDS loading buffer (Invitrogen) and 25g of protein was loaded
onto 4 –12% SDS-PAGE gradient gels (Invitrogen) and subsequently
transferred by semidry or wet transfer onto a PVDF membrane (Trans-
blot Turbo Mini PVDF, Bio-Rad). The blots were blocked in 5% BSA in
Tris-buffered saline with Tween and incubated overnight with primary
antibodies at 4°C. Primary antibodies used in this study and their work-
ing dilutions are listed in Table 1. To detect protein signal, the following
horseradish peroxidase (HRP)– conjugated secondary antibodies were
used: goat anti-rabbit IgG (H  L)-HRP conjugate (1:6000, 1706515,
Bio-Rad) and goat anti-mouse IgG1 heavy chain (HRP) (1:6000,
ab97240, abcam). Chemiluminescence detection of proteins was per-
formed with Luminata Crescendo Western HRP Substrate (Merck
Millipore) with a Chemidoc Imaging System (Bio-Rad). Bands were
quantified using Fiji software.
Results
Impact of congenital CMV infection on growth and hearing
In utero intraplacental inoculation of murine CMV was per-
formed in timed pregnant mice (E13) under deep anesthesia (Fig.
1A,B). Earlier studies demonstrate that this model recapitulates
many features of congenital human CMV infection (Sakao-
Suzuki et al., 2014). First, we confirm that transplacental CMV
inoculation causes fetal infection using saliva PCR assay for CMV
genome detected in virus-inoculated mice, but not in CTL mice
(saliva specimen collected at W3: n  12 CMV, n  13 CTL).
Second, we found a strong male bias at birth for both CTL and
CMV groups (male/female ratio: CTL: 3.25; CMV: 2.36, Fisher’s
exact test, p  0.62, n  34 CTL, n  47 CMV). These findings
suggest a differential survival rate of embryos due to both the
transplacental inoculation and the virus injection. In humans,
the sex ratio seems more favorable to girls in case of congenital
CMV infection (Watt et al., 2016). Third, we confirmed that our
model induces developmental retardation reminiscent of con-
genital CMV infection in humans (Fig. 1C, mean  SEM body
weight at 8 d: CTL: 7.065  0.1 g; CMV: 6.44  0.11 g, Mann–
Whitney U (52) 151, p 0.0005, n 21 CTL, n 35 CMV).
Severe growth retardation was observed in 25% of 8-postnatal
day-old offsprings exposed to infection in utero (nine pups of 34),
consistent with a previous report (Li and Tsutsui, 2000). Third,
we confirmed that this model develops a progressive hearing loss
phenotype reminiscent of what has been reported in infants with
congenital CMV infection (Fig. 1D,E, CMV vs CTL). Recordings
of ABRs show an age-dependent sensorineural hearing loss in
CTL and CMV-infected mice (Fig. 1E, W4 vs W16: hearing
threshold: CTL: Wilcoxon matched-pairs signed-rank test, p 
0.0156; CMV: Wilcoxon matched-pairs signed-rank test, p 
0.0078, n 8 CTL, n 8 CMV). ABRs showed no difference in
hearing thresholds between control and infected mice at W4 after
birth, but increased by 
20 dB in W16 infected mice (Fig. 1E,
CMV vs CTL: hearing threshold: W4: Mann–WhitneyU(14) 24,
p 0.44; W16: Mann–WhitneyU(16) 2, p 0.0005, n 8 CTL,
n  8 CMV), consistent with previous reports (Juanjuan et al.,
2011; Schachtele et al., 2011; Bradford et al., 2015). Altogether,
these findings indicate that transplacental CMV inoculation
causes fetal infection, growth retardation, and progressive hear-
ing deterioration in mice.
Impact of congenital CMV infection on neonate olfaction
To address olfactory abilities in very young pups following con-
genital CMV infection, we recorded their ultrasonic vocalizations
emitted when exposed to odorants in an olfactometer (Fig. 2).
We found that pups with placental CMV infection exhibited im-
paired olfactory perception as early as 6 d after birth (Fig. 2). After
separation from their mothers and isolation in an olfactometer
chamber, preweaning pups aged 6 – 8 d produced ultrasonic calls
that promoted mother– offspring interaction (Fig. 2A–F), con-
sistent with previous reports (Branchi et al., 1998; Lemasson et
al., 2005). CMV-infected pups also emitted such ultravocaliza-
tions following isolation as a distress signal (Fig. 2E,H,I). No
Table 1. Detailed information on the primary antibodies used in this study
Antibody (anti-) Manufacturer, catalog # Marker of Working dilution
Actin Sigma-Aldrich, A5441 Housekeeping protein 1:6000
Atg5 Cell Signaling Technology, 12994 Autophagy initiation 1:1000
Beclin1 Cell Signaling Technology, 3495 Autophagosome induction 1:1000
CB Swant, 300 Calbindin interneurons 1:2000
CMV S. Jonjic gift IE1 protein of the murine virus 1:1000
CR Swant, 7699/3H Caretinin interneurons 1:2000
Active casp3 Cell Signaling Technology, asp175 Apoptotic cells 1:300
CD68 Serotec, MCA1957GA Activated microglia 0.5g/ml
Iba1 Wako Chemicals, 016-20001 Microglia 1:500
Ki67 Abcam, 15580 Proliferating cells 1:1000
Lamp1 Abcam, 24170 Lysosomes (autophagy) 1:1000
LC3 Sigma-Aldrich, L7543 Autophagic flux 1:2000
OMP Wako, 544-10001 Olfactory sensory neurons 1:1000
P62 Abnova, H00008878-M01 Autophagic flux 1:1000
pAMPK1 Cell Signaling Technology, 2531 Metabolic signalling 1:1000
pmTOR Cell Signaling Technology, 2971 Immune signalling 1:1000
TH ImmunoStar, 22941 Dopaminergic neurons 1:4000
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Figure1. Impact of CMV congenital infection on hearing.A, Timetable of the experiments.Micewere infectedwith CMVor received PBS at E13. Theywere analyzed using olfactometers andwith
buried food-finding tests. Their ABRs were recorded twice, at W4 andW16. B, Animal model of CMV infection in pregnancy. Murine CMV or PBS was intraplacentally inoculated in each embryo of
pregnantmice under deep anesthesia. C, Bodyweight of the 8-postnatal day-oldmice after infectionwithmurine CMVat day 13 of gestation (n 21 CTL, n 35 CMV). CTLmicewere injectedwith
saline only. Outlierswere identified by ROUT. Variances between the CTL and CMVgroupswithout outliers are different (F(33,19) 2.433, *p 0.05), underlying the growth retardation of 9/34 CMV
pups. D, Click-evoked ABR waveforms at different sound intensities. E, ABR hearing thresholds for a click. n 8 male mice per group. p-values were calculated by Mann–Whitney test (C, D:
comparison between CTL and CMV groups) or Wilcoxon matched-pairs signed–rank test (D: comparison between W4 and W16 for each mouse group). *p 0.05; **p 0.01, ***p 0.001;
mean SEM in bar graphs.
Figure 2. Impact of CMV congenital infection on neonate olfaction. A, Emission and quantitation of ultrasonic vocalizations. The recording of ultrasonic calls began 30 s after placing the pups in
the test chamber of the olfactometer. Ultrasonic vocalizations were detected using an ultrasonic microphone connected to a bat detector that converts ultrasonic sounds to the audible frequency
range. B, Timetable of the experiments. Mice were infected in utero with CMV or received PBS at E13. They were analyzed using olfactometers at 6 and 8 d after birth. C, Typical wave traces of
spontaneous call series from preweaning 6-day-old pups after congenital CMV infection. CTL mice were inoculated with PBS only. D, Experimental paradigm. Ultrasonic emission responses were
recorded during the first periodwithout odorant (1min), followed by a period of odorant exposure (1min) and finally the last period of exhaust odorant (1min and 30 s). E–G, Emission of ultrasonic
calls for citral odorant on day 6 after birth (n 18 CTL, n 19 CMV).H, I, Emission of ultrasonic calls formale scent odorant on day 8 after birth (n 8 CTL, n 11 CMV). p-values were calculated
by Mann–Whitney test (E) or Wilcoxon matched-pairs signed–rank test (H, I ). **p 0.01, ***p 0.001, ****p 0.0001; mean SEM in E.
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difference in the number of emitted ultravocalizations was found
between CTL and CMV-infected pups (Fig. 2E, CTL vs CMV:
number of calls/min in the first minute of isolation with no ol-
factometer emission of odorant: Mann–Whitney U(35)  169.5,
p 0.97, n 18 CTL, n 19 CMV), as well as between male and
female pups of the two groups (data not shown). As expected and
consistent with previous studies (Branchi et al., 1998; Lemasson
et al., 2005), CTL pups decreased their emission of calls in re-
sponse to exposure to nonsocial or social odorant molecules such
as citral or male scent, respectively (Fig. 2F,H, no odorant vs
citral, Fig. 2F: number of calls/min: Wilcoxon matched-pairs
signed–rank test, p  0.0001, n  18 CTL; no odorant vs male
scent, Fig. 2H: number of calls/min: Wilcoxon matched-pairs
signed–rank test, p 0.0078, n 8 CTL). In contrast, congenital
CMV infection impaired the ultrasonic call responses triggered
by the two scents, indicating an alteration of olfactory perception
induced by the virus (Fig. 2E,G,I). Figure 2, E and G, reveals
olfactory dysfunction as seen by the lack of inhibition of ultravo-
calizations when pups were exposed to citral as early as the sixth
day after birth (Fig. 2E, CTL vs CMV: number of calls/min when
citral exposition: Mann–Whitney U(35)  61.5, p 0.0005, n
18 CTL, n  19 CMV; Fig. 2G, CMV:
number of calls /min when citral exposi-
tion, Wilcoxon matched-pairs signed–
rank test, p  0,67, n  19 CMV).
Similarly, Figure 2I shows impairment in
detecting male scent in CMV-infected
mice (no odorant vs male scent: number
of calls/min: Wilcoxon matched-pairs
signed–rank test, p 0.99, n 11 CMV).
Impact of congenital CMV infection on
odorant detection in weaning mice
Given the early detrimental effects of
congenital CMV infection in neonate ol-
faction, we assessed olfactory-driven be-
havior of infected mice at W16 after in
utero viral inoculation to investigate po-
tential long-lasting effects. Consistent
with defective olfaction, CMV-infected
mice exhibited impaired hidden food
search (Fig. 3A, CMV vs CTL: latency: Ge-
han–Breslow–Wilcoxon test, 2  4.032,
p  0.045, n  11 male CTL, n  8 male
CMV), but not when food was made visi-
ble (Fig. 3B, CMV vs CTL: latency:
Gehan–Breslow–Wilcoxon test, 2 
0.007, p 0.935, n 11 male CTL, n 8
male CMV). This latter control paradigm
indicates that the deficit in this behavioral
test is genuinely olfactory and not related
to another modality. Three olfactory di-
mensions could be compromised by CMV
infection: odorant detection, discrimina-
tion, and/or learning. To specify whether
they were equally impaired, congenitally
infected mice were tested 1 month after
birth using automated olfactometers (Fig.
3C).
We investigated olfactory sensitivity by
determining the detection threshold for
n-butanol odorant using the descending
method of limits in a two-odorant rewarded
discrimination task. Mice were subjected to two sessions per day
with a one decimal dilution of the odorant per session. As shown in
Figure 3D, CMV-infected mice needed more trials to learn to distin-
guish between n-butanol and its water solvent (CMV vs CTL: block
number to criterion: Gehan–Breslow–Wilcoxon test, 2  8.945,
p  0.028, n  11 male CTL, n  8 male CMV). CMV infection
resulted in an increase of approximately three orders of magnitude
in the detection threshold of the odorant (Fig. 3E, left, CMV vs CTL:
threshold: Mann–WhitneyU(15) 9, p 0.0104,n 11 male CTL,
n  6 male CMV). Although all control mice were able to detect
diluted n-butanol, two CMV-infected mice of eight were unable to
achieve the performance criterion even for pure n-butanol (Fig. 3E,
right). We therefore conclude that congenital CMV infection dra-
matically impairs odorant detection in neonate as well in adult mice,
thus affecting several critical olfactory-driven behaviors.
Impact of congenital CMV infection on odorant
discrimination and olfactory memory
Given the strong effects of CMV on olfactory perception, we
investigated the possible impact on olfactory discrimination. The
same paradigm was used in weaning male mice for simple olfac-
Figure 3. Impact of CMV congenital infection on olfactory perception in adult malemice. A,B. Latency to find the buried (A) or
visible (B) food reward in the buried food-finding test. Results are percentage of mice that did not find the food over a 15 min
period. C, Go–no go procedure. The olfactometer isolator comprises an odorant sampling port and awater delivery tube to reward
mice. Animals are trained to distinguish between 2 odorants: a positive stimulus (S) and a negative stimulus (S	). A licking
response followinganS trial andno licking followinganS	 trialwere scored as correct.D, percentageofmice that didnot reach
the criterion performance (75% correct responses in the block) on a discrimination task using n-butanol (10	3 dilution) and its
solvent. A block is a series of 20 trialswith random10 S and 10 S	. E, Effects of congenital CMV infection on olfactory detection.
Results are expressed as detection thresholds (	log10 of odorant dilution;mean SEM) for n-butanol (left) or the percentage of
mice for the last dilutionperformance criterion (right). Results inA,B, andFare expressedas themeanSEMof correct responses.
n 8 CMV, n 11 CTL. p-values were calculated by Gehan–Breslow–Wilcoxon test (A,B,D) andMann–Whitney test (E). *p
0.05; **p 0.01.
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tory discrimination between two odorants and for difficult olfac-
tory discrimination between binary mixtures of odorants (Fig. 4)
using strong concentrations. We found that CMV-infected mice
have altered odorant discrimination, in particular when binary
mixtures of monomolecular odorants were used (i.e., difficult
task). CMV infection alters the ability of mice to learn to discrim-
inate between isoamylacetate and anethol (Fig. 4A, repeated-
measures two-way ANOVA,Fvirus(1,17) 5.837, p 0.027). In the
difficult discrimination task of isoamylacetate–anethol mixtures
(Fig. 4B), the 6/4 versus 4/6 mixtures could not be correctly dis-
criminated by CTL and CMV-infected mice (Fig. 4B, right).
When using more contrasted mixture (e.g., 8/2 vs 2/8 mixtures)
only CTL mice discriminated the odorants, whereas CMV-
infected animals performed the task at chance level (Fig. 4B, left,
Figure 4. Impact of CMV congenital infection on olfactory discrimination in adultmalemice.A,B, Graph depicting the percentage of correct responses in each block of the easy (A) discrimination
task between isoamylacetate (S) and anethol (S	) or the difficult (B) discrimination tasks between their binary mixtures. The mixture ratio of isoamylacetate and anethol is indicated on the
graph. C–E, Percentage ofmice that did not reach the performance criterion for the discrimination task between isoamylacetate and anethol (C), D-limonene and citronellal (D), and D-limonene and
anethol (E). F, Long-termmemory test. To assess olfactory memory, mice were trained during 5 consecutive days to recall distinguishing D-limonene and anethol. Mice were then retested at W16
following the end of the training session (W12). InA,B, and F, a score of 50% corresponds to the success rate expected on the basis of chance alone (dashed line). Results inA,B, and F are expressed
as themean SEM of correct response. n 8 CMV, n 11 CTL. p-valueswere calculated by ANOVAwith repeated-measures (A,B), Gehan–Breslow–Wilcoxon test (C–E), orMann–Whitney test
(F ). *p 0.05, **p 0.01.
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repeated-measures two-way ANOVA, Fvirus(1,17)  14.63, p 
0.0014). Even when infected mice successfully completed two-
odorant discrimination tasks in easy problems (simple discrimi-
nation between two odorants), they needed more trials to
complete these tasks. CMV-infected mice required more trials
than CTL to learn to discriminate between isoamylacetate and
anethol (Fig. 4C, CMV vs CTL: block number to criterion: Ge-
han–Breslow–Wilcoxon test, 2 4.56, p 0.033, n 11 male
CTL, n  8 male CMV), D-Limonene and Citronellal (Fig. 4D,
CMV vs CTL: block number to criterion: Gehan–Breslow–Wilc-
oxon test, 2  7.425, p 0.006, n 11 male CTL, n 8 male
CMV) or D-limonene and anethol (Fig. 4E, CMV vs CTL: block
number to criterion: Gehan–Breslow–Wilcoxon test, 2 4.735,
p 0.03, n 11 male CTL, n 8 male CMV).
Analysis of long-term olfactory memory suggests no differ-
ences between CMV-infected and CTL mice despite a trend for
lower score in infected animals (Fig. 4F, CMV vs CTL: percentage
correct responses at W16: Mann–Whitney test, U(17) 27.5, p
0.1788, n 11 CTL, n 8 CMV). Altogether, these data indicate
that CMV-inoculated mice exhibit poorer odorant detection and
olfactory discrimination, whereas their olfactory memory seems
intact.
Congenital CMV infection leads to OB neuroinvasion,
apoptosis, and inflammation
Bridging the nose to higher brain structures, the OB circuit con-
stitutes the first central relay station of the olfactory system. The
olfactory deficits we reported here may result from damage to the
OB circuit by CMV-induced lesions in the placenta and/or im-
pairment of the olfactory system (Fig. 5A). Immunohistochemi-
cal analysis of brains at W3 after birth reveal viral expression in all
the OB layers of CMV-infected male mice (Fig. 5B), as well all in
the SVZ (Fig. 5D, down), consistent with previous studies (Han et
al., 2007; Cekinovic´ et al., 2008). These data indicate that, in our
animal model, transplacental CMV inoculation causes embryo
infection, neuroinvasion, and long-term viremia in the OB last-
ing at least 3 weeks after birth. Moreover, immunohistochemistry
and immunoblot experiments revealed that viral expression in
the OB is accompanied by increased apoptosis (Fig. 5B,C). In
particular, we found an increased number of cleaved Caspase 3
(Casp3)-positive apoptotic cells (Fig. 5B), as well as substantially
increased levels of Casp3 in CMV-infected mice at W3 compared
with CTL mice by immunoblot analysis of OB proteins (Fig. 5G,
CMV vs CTL: Casp3: Mann–Whitney test, U(6) 0, p 0.0286,
n 4 mice per group).
The OB hosts a large population of resident microglial cells,
the innate immune cells of the brain. OB microglial cells can be
activated in response to pathological tissue changes, thus migrat-
ing to the site of injury, where they proliferate and acquire new
functions including phagocytic activity and cytokine secretion
(Lazarini et al., 2012, 2014; Hasegawa-Ishii et al., 2017). Recent
studies have indicated a critical role of OB microglia in olfactory
processing (Seo et al., 2016; Denizet et al., 2017; Reshef et al.,
2017). We used Iba1, a marker of both unactivated and activated
microglia, to visualize these immune cells in the OB of CMV-
infected mice at W3 (Fig. 5D, middle, E). We found that congen-
ital CMV infection activates OB microglia, as indicated by a
change in morphology (Fig. 5E), an increased number of Iba1-
positive cells in all OB layers (Fig. 5E), and an increased expres-
sion of Iba1 and CD68, markers of activated microglia (Fig. 5C–
E). Consistent with immunochemistry results, we found
substantially increased levels of Iba1 and CD68 in CMV-infected
mice at W3 compared with CTL mice by immunoblot analysis of
OB proteins (Fig. 5C,G, CMV vs CTL: Mann–Whitney test, Iba1:
U(6) 0, p 0.0286; CD68: U(6) 0, p 0.0286, n 4 mice per
group). Together, these findings reveal that congenital CMV in-
fection causes fetal infection and leads to viral expression in the
OB at W3 that is accompanied by increased apoptosis and
inflammation.
Congenital CMV infection alters OB neuron content
The level of neuroinflammation and apoptosis in the OB of
CMV-infected mice at W3 prompted us to investigate whether
infection and inflammation disrupted normal OB development
and if a specific neuronal population was targeted. We observed
neither global change in the bulbar architecture nor histologic
changes in the lamination of the OB (Fig. 5D, middle). In partic-
ular, the mitral cell layer was similar in shape and size to those of
CTL, suggesting no damage of these projection cells. Despite the
presence of viral particles and microglial activation, OSN inner-
vation to the OB of CMV-infected mice was also similar to CTLs
(Fig. 5D). Consistent with those observations made in the OB, the
OE was similar in shape and size to those of CTL (thickness of the
OE, mean  SEM: CTL: 70.02  2.91 m; CMV: 72.08  2.86
m, CMV vs CTL: Mann–Whitney test, U(11)  18, p  0.701,
n  6 CTL, n  7 CMV). The number of OSNs also remained
unchanged, suggesting no damage of sensory neurons (mean 
SEM cell density of OMP-positive cells (10 4)/mm 3: CTL:
40.44 4.20; CMV: 37.61 3.67, CMV vs CTL: Mann–Whitney
test, U(10) 14, p 0.631, n 5 CTL, n 7 CMV).
We subsequently assessed whether the increase in cell apopto-
sis induced by CMV infection could lead to substantial changes in
neuronal subpopulations by visualizing CB-, calretinin (CR)-,
and TH-positive interneurons (Fig. 5F). CB- and CR-positive
cells belong to the periglomerular neuron population that sur-
rounds the glomeruli. TH, the rate-limiting enzyme required for
the synthesis of dopamine, is localized in periglomerular neurons
and short axon cells. CB-, CR,- and TH-positive cells also contain
GABA and glutamic acid decarboxylase, the rate-limiting enzyme
for GABA biosynthesis. We found that CMV-infected mice
showed a reduced population of TH-positive cells in the OB
glomeruli at W3 after birth (Fig. 5F,H, CMV vs CTL: Mann–
Whitney test, U(10)  4, p  0.026; n  6 mice per group). We
also observed a decreased population of CB-positive cells in the
glomeruli of these infected mice at W3 (Fig. 5F,H, CMV vs CTL:
Mann–Whitney test, U(9)  0, p  0.0043; n  5 CTL, n  6
CMV). In contrast, the cell density of CR-positive cells was sim-
ilar to CTL mice, indicating a higher vulnerability for bulbar
dopaminergic and CB- expressing neurons to CMV infection
(Fig. 5F,H, CMV vs CTL: Mann–Whitney test, U(6)  6, p 
0.6571; n  4 mice per group). The depletion of TH- and CB-
positive cells observed in infected animals might reflect a direct
viral tropism for this neuronal category or result from neuro-
inflammation-induced cell death and/or reduced neurogenesis.
It is important to note that the neurogenic SVZ provides the
postnatal OB with interneurons throughout its lifespan in ro-
dents. This area gives rise to thousands of neuroblasts per day that
migrate via the RMS toward the OB, where they functionally
integrate with preexisting neuronal circuits and differentiate
mostly into granule cells and periglomerular interneurons (Fig.
5A; Lledo et al., 2006). Interestingly, we found a decrease in cell
proliferation in the SVZ at W3 (Fig. 5D,H, CMV vs CTL male
mice: Mann–Whitney test, U(9) 0, p 0.0043; n 6 CTL, n
5 CMV), supporting the hypothesis that CMV might affect SVZ
neural progenitor cell proliferation and thus postnatal neurogen-
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Figure 5. Impact of CMV congenital infection on the postnatal olfactory system atW3. A, Sagittal section of amurine brain showing the neurogenic dentate gyrus (DG) of the hippocampus, the
neurogenic SVZ, the RMS, and the OB. Neuroblasts born in the neonatal and postnatal SVZ migrate via the RMS until the OB, where they differentiate into GCL or GL interneurons. B, D–F,
Representative staining of coronal SVZ (D, bottom) and OB slices with DAPI (B, D, E) murine CMV IE1 (B, D, bottom), cleaved caspase 3 (Casp3, D, top), OMP expressed by OSN (D, middle), Iba (D,
middle; E), CD68 expressed by activatedmicroglia andmacrophages (E), Ki67 (D), TH (F ), CB (F ), and CR (F ), antibodies showing CMV, apoptotic Casp3, OSN,macrophages, microglia, Ki67
neural progenitor cells, TH, CB and CR cells in CTL and congenital CMV-infected mice at W3 after birth. C, G–I, Screening of the OB proteins from congenital CMV-infected mice at W3 for
autophagy induction (C, I ), cell apoptosis (C,G), andmicroglial reaction (C,G). Lysates were extracted from the OB of CTL and congenital CMV-infectedmice atW3 and analyzed by immunoblot (C)
using antibodies to detect Casp3, Iba1, CD68, Beclin1, phospho-AMPK, Atg5, p62, LC3 I/II, LAMP, phospho-mTOR, and actin (threemice each). The levels of Casp3, Iba, CD68, Beclin1, pAMPK, Atg5,
p62, LC3 II/ LC3 I, LAMP, pmTOR, and actin were quantified (G,I ) by band intensity with Fiji software.H, J, Ki67, TH, CB, and CR cell densities in the SVZ, GL, glomerulus (glom), and GCL
atW3 following congenital CMV inoculation. Allmice areW3-oldmales injected at E13with PBS (CTL) or CMV. For immunoblot analysis (G, I ), n 4mice per group. For cell density analysis (H ) and
area ratio (J ), n 4–6mice per group. For glom size (J ), n 409 glom from 4 CTL, n 352 glom from 4 CMV. Results are shown as mean SEM. p-values were calculated by Mann–Whitney
test. *p 0.05, **p 0.01. Scale bars: 100m in D, bottom; 50m in B, D, middle, and F; 25m in D, bottom; and 5m in D, top, and E.
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esis in mice (Mutnal et al., 2011). However, further experiments
are needed to characterize the precise populations that are lost in
the SVZ, the fate of the proliferating survivor cells, and the impact
on neuronal progenitor migration and survival.
Finally, we assessed whether the decrease in the amount of
interneurons could change the OB size. Our anatomical investi-
gations demonstrated that CMV OB neuroinvasion was accom-
panied by differential changes in the relative size of the different
layers of the OB at W3, including the RMS, GL, and GCL (Fig.
5J), which is composed of GABAergic interneurons that regulate
the neuronal activity of output OB neurons. To address the viral
impact on the OB innervation from the periphery, we measured
the glomerulus area using OMP staining. Congenital CMV
infection decreased the mean size of glomeruli in infected
male animals at W3 (Figs. 5J, 6D; glomerulus area: CMV vs CTL;
Mann–Whitney test, U(6)  0, p  0.0286, n  4 CTL (409
glomeruli), n 4 CMV (304 glomeruli). Additionally, the RMS/
GCL area ratio is decreased in infected animals (Fig. 5J, CMV vs
CTL; Mann–Whitney test, U(16)  14, p  0.025, n  10 CTL,
n  8 CMV). We found a correlation between RMS and GCL
sizes in CTL OBs (Spearman r 0.782, p 0.011, n 11 CTL),
but not in CMV-infected animals (Spearman’s r  0.333, p 
0.428, n  8 CMV), suggesting that congenital CMV infection
differentially alters the development of these OB cell layers, thus
leading to disproportionate OB structure. A slight difference be-
tween CTL and CMV was found for either body weight (mean
SEM in CTL: 18.53  0.50 g; in CMV: 16.94  0.54 g; Mann–
Whitney test, U(46)  160.5, p  0.0257, n  17 CTL, n  31
CMV or brain weight (meanSEM in CTL: 500.8 14.42 mg; in
CMV: 464.4 7.934 mg, Mann–Whitney test, U(46)  172, p
0.0490, n 17 CTL, n 31 CMV). However, no correlation was
found between body and brain weight for each group (data not
shown). Finally, no correlation was found between RMS and GL,
GCL and GL, GL and the mouse body weight, or brain weight and
body weight at W3 in the both groups (data not shown). There-
fore, CMV-infected preweaning male mice exhibit OB propor-
tionate and disproportionate developmental abnormalities,
neuroinflammation, and fewer bulbar interneuron cells that to-
gether might contribute to an olfactory deficit.
Figure6. Long-lasting impact of CMV congenital infection on the adult OB.A, Representative staining of coronal SVZ (top) andOB (middle, bottom) sliceswith Ki67 (top), TH (middle) andmurine
CMV IE1 (bottom).B–D, Ki67 cell densities in theSVZ (B), TH cell densities in theGL (C), andglomerulus size (D) atW16after birth following congenital CMV inoculation. For cell density analysis,
n 5male CTL, n 2 female CTL, n 4male CMV, n 4 female CMV. For glomerulus size, n 212 glomeruli from 2 CTL females, n 409 glomeruli from 4 CMV females, n 499 glomeruli
from 4 CTLmales, n 262 glomeruli from 4 CMVmales. Results inD are shown asmean SEM. p-values were calculated byMann–Whitney test. *p 0.05, ***p 0.001. Cc, Corpus callosum;
LV, lateral ventricle; str, striatum. Scale bars: 100m in A, top; 50m in A, middle and bottom).
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Congenital CMV infection increases hallmarks of autophagy
in preweaning mice
Given the high degree of bulbar apoptosis and neuroinflamma-
tion induced by congenital CMV infection, we investigated the
impact of this virus on the levels of several protein markers of
autophagy in the OB at W3 (Fig. 5C,I). Beclin1 is a key
autophagy-related protein that participates in the induction and
formation of autophagosomes. Microtubule-associated protein 1
light chain 3 (LC3) is specifically associated with autophagosomal
membranes and plays a critical role during the expansion step of
autophagosome formation. LC3 has two forms, nonlipidated
(LC3 I) and lipidated (LC3 II). Initiation of autophagy is charac-
terized by the formation of LC3 II via conjugation of LC3I to
phosphatidyletholamine. This conjugation needs the activation
of autophagy related 5 protein (Atg5). P62 is specially degraded in
autolysosomes and thus is widely used to monitor autophagic
flux. Lysosomal-associated membrane protein 1 (LAMP1) is a
glycoprotein responsible for maintaining lysosomal integrity.
However, measuring the expression of Beclin1, LC3I, LC3 II,
Atg5, and LAMP1 provides a good indication of the extent of
autophagy (Mizushima and Levine, 2010).
Western blot analysis of OB proteins from CMV-infected
mice showed increased autophagic activity, including in-
creased levels of Beclin1 and Atg5 (Fig. 5C,I, CMV vs CTL:
Mann–Whitney test, Beclin1: U(6) 0, p 0.0286; Atg5: U(6)
0, p 0.0286). The levels of autophagosome formation are par-
ticularly elevated, as demonstrated by our evidence for a fourfold
increase in Beclin1 expression (Fig. 5I). We found a trend for
enhanced expression of LAMP1 (Fig. 5C,I, CMV vs CTL: Mann–
Whitney test, U(6)  1, p  0.0571). The dramatic increase in
Beclin1 expression prompted us to investigate whether the
pAMP-activated protein kinase (pAMPK)-mammalian target of
rapamycin (mTOR) signaling pathway is involved. In this meta-
bolic signaling pathway, situated upstream of the autophagic
pathway, pAMPK activation upregulates the cellular energy
needed for autophagy induction and inhibits mTOR, leading to
beclin1 engagement (Mizushima and Levine, 2010). We found
no significant changes in the pAMPK and pTOR expression (Fig.
5C,I, CMV vs CTL: Mann–Whitney test, pAMPK: U(6) 4, p
0.3429; PTOR: U(6) 3, p 0.2000), suggesting no involvement
of this metabolic signaling pathway in our viral model.
Finally, we investigated the modulation of p62 and LC3 au-
tophagic markers involved in the autophagic flux. We found a
twofold increase in p62 expression that indicates an increase in
the autophagosome clearance and thus in the autophagic flux
(Fig. 5C,I, CMV vs CTL: Mann–Whitney test, U(6)  0, p 
0.0286). Western blot data also reveal an increase in the LC3II/I
ratio, further suggesting that congenital CMV increases au-
tophagic flux (Fig. 5C,I, CMV vs CTL: Mann–Whitney test, U(6)
 0, p  0.0286). Altogether, our data indicate that congenital
CMV infection results in the upregulation of autophagy at W3
that might support neuroinflammation and cell apoptosis.
Long-lasting effect of congenital CMV infection on the
olfactory system
Given the structural abnormalities of both the SVZ and OB at W3
and the long-lasting olfactory deficits induced by congenital
CMV infection, we assessed the long-term consequences for the
olfactory system in adult male and female mice at W16 (Fig. 6).
We found a decrease in cell proliferation in the SVZ at W16 after
birth (Fig. 6A,B, CMV vs CTL: LC3 ratio: Mann–Whitney test,
U(13) 10, p 0.0401, n 8 CTL, n 7 CMV), supporting the
view that CMV congenital infection results in a long-term reduc-
tion of postnatal cell proliferation in this neurogenic zone. No
difference was found between males and females in either the
CTL or CMV group (data not shown). Anatomical investigations
of the OB of CMV-infected mice reveal viral expression in all
layers of this structure at W16 after birth (Fig. 6A), but no pro-
liferation or activation of local microglia (data not shown). These
findings indicate that, at least in our animal model, CMV placen-
tal infection leads to long-term viral infection of the embryos and
transient neuroinflammation in the OB. No difference was found
for either the body or the brain weight between CTL and CMV
(data not shown).
Moreover, we found that CMV-infected mice showed a per-
sistent reduction in the population of dopaminergic TH cells in
the OB glomeruli at W16 (Fig. 6A,C; CMV vs CTL: Mann–Whit-
ney test, U(12)  5, p  0.0111, n  7 CTL, n  7 CMV). No
difference was found between males and females in either the
CTL or CMV group (data not shown). The cell densities of the
two other glomerular populations, CB- and CR-positive cells, are
similar to CTL mice, indicating a recovery for the CB-positive cell
population compared with the W3 earlier time point. This recov-
ery might probably result from ongoing adult neurogenesis. The
reduction of glomerular TH-positive cell number in infected an-
imals is similar in magnitude for the two time points, W3 and
W6, indicating a higher vulnerability for bulbar dopaminergic
neurons to CMV infection. Their loss in this context is accompa-
nied by a reduced mean size of glomeruli in infected animals (Fig.
6D, glomerulus area: CMV vs CTL; Mann–Whitney test, all mice:
U(14) 2, p 0.0006, n 8 mice per group; males:U(10) 0, p
0.0286, n  4 male mice per group; females: U(10)  0, p 
0.0286, n  4 females per group). No difference was found be-
tween males and females in either the CTL or CMV group (data
not shown). Conversely, the difference in the GCL size that we
observed at W3 did not persist later at W16, suggesting a recovery
for the GCL interneuron population likely due to the ongoing
adult neurogenesis (data not shown). Thus, congenital CMV in-
fection leads to long-term alteration of the OB structure, com-
promised cell proliferation in the SVZ, and fewer bulbar
dopaminergic cells that together might contribute to the olfac-
tory deficit that we report here in infected mice.
Discussion
We identify olfactory deficit as early sensory impairment much
before hearing deterioration, making hyposmia an early func-
tional consequence of congenital CMV infection in mice. We
show, for the first time, that placental CMV inoculation of em-
bryos results in viral infection of the OB, transient activation of
microglial cells, disproportionate OB cell layers, and alteration
of the OB interneuron development and impairment of the sense
of smell long before auditory deficits emerge. These findings con-
firm and extend previous work showing CMV-induced OB le-
sions in human fetuses (Teissier et al., 2014) and the importance
of OB interneurons in processing properly olfactory information
(Kobayakawa et al., 2007; Khodosevich et al., 2013; Lazarini et al.,
2014; Grelat et al., 2018).
In the present study, we used in utero intraplacental inocula-
tion of murine CMV as a model to study CMV infection during
human pregnancy. Previous studies demonstrate that this mu-
rine model recapitulates many features of congenital human
CMV infection, such as altered hindbrain morphogenesis, robust
CNS neuroinflammation, infection of the inner ear, and lesions
responsible for deafness (Li et al., 2000; Koontz et al., 2008; Kos-
mac et al., 2013; Sakao-Suzuki et al., 2014; Bradford et al., 2015).
CMV is species specific, but the murine CMV genome is highly
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similar to that of the human CMV (Rawlinson et al., 1996). It is
important to note that susceptibility to CMV infection is age
dependent and host maturation is associated with decreased virus
replication and less severe neurological outcomes in both hu-
mans and mice (Tsutsui, 2009; Muller et al., 2010). Indeed, in
humans and rodent models, vulnerability to neurological com-
plications depends on both the maturation of the immune system
and a decreased susceptibility of maturing neurons to infection
and cell death (Oliver et al., 1997; Schultz et al., 2015; Almishaal et
al., 2017). Therefore, we chose an in utero infection model with
the well characterized murine CMV Smith strain, which is known
to replicate in the brain and induce neuropathology following
transplacental inoculation (Li et al., 2000). In vivo studies of con-
genital human CMV infection are limited due to the strict host
specificity of CMV. In contrast to human CMV, murine CMV
rarely crosses the placenta, except when it is directly inoculated in
this tissue. The virus then disseminates to other tissues of the
embryo including liver, lung, salivary glands, and brain, where
infection results in widespread encephalitis (Li and Tsutsui, 2000;
Juanjuan et al., 2011; Sakao-Suzuki et al., 2014). Here. we provide
experimental evidence that CMV can infect the OB following in
utero transplacental inoculation, consistent with previous reports
on rodent models and our observations in human fetuses
(Cekinovic´ et al., 2008; Teissier et al., 2011, 2014). Moreover, we
show that this OB viral expression persists for a long time because
viral expression was detected in OB cells at both W3 and W16
after birth.
We also report for the first time that the OB viral infection is
accompanied by increased autophagy. Autophagy is a highly con-
served process involved in the turnover of damaged organelles
and long-lived proteins in both physiological and pathological
conditions (Nakatogawa et al., 2009). This degradative pathway
involves the sequestration of cytoplasmic constituents within
double-membrane-bound compartments called autophagosomes
and delivery of the contents to lysosomes for degradation and
recycling. Recent studies have shown important roles for au-
tophagy genes in cell apoptosis, neuroinflammation, and neuro-
genesis (Maiuri et al., 2007; Cloe¨tta et al., 2013; Deretic et al.,
2013). Autophagy is also frequently seen as a mechanism to de-
grade microorganisms including viruses that invade intracellu-
larly (Levine et al., 2011). Consistent with a link between
autophagy and human CMV infection (Chaumorcel et al., 2008;
McFarlane et al., 2011), we show increased autophagic activity
including increased levels of essential autophagy components
such as Beclin1, Atg5, and p62.
We found an increase in cell apoptosis in infected OB at W3,
consistent with previous studies (Kosugi et al., 1998). The up-
regulated autophagy might support OB apoptosis because over-
active autophagy leads to a high turnover rate of organelles and
proteins, thus promoting cell death (Maiuri et al., 2007). Micro-
glial activation in the brain after CMV infection was recorded in
several studies, but the autophagy stimulus for this effect was not
investigated (Ibanez et al., 1991; Koontz et al., 2008; Cloarec et al.,
2016; Brizic´ et al., 2017). Consistent with a link between au-
tophagy and neuroinflammation (Deretic et al., 2013), our find-
ings reveal activation of both autophagy and microglial cells in
the infected OB at W3. Interestingly, autophagy activation did
not persist at later time points; nor did neuroinflammation, sug-
gesting an immune control of the virus at the adult stage (data not
shown). Further experiments on the time course of OB viral rep-
lication, autophagy, and neuroinflammation should shed light
on the viral mechanisms of neuronal loss in this model.
The dramatic loss of smell induced by congenital CMV infec-
tion might be due to direct neuron damage into the olfactory
system or be an indirect defect in neuron development. Because
the onset of olfactory loss presumably occurs secondary to the
viral insult, a direct damage of OSNs is likely. For instance, a
direct in utero infection of OSNs followed by viral propagation to
the OB via OSN axons might lead to infection of the OB tissue. In
the present study, we show that, despite the presence of viral
particles in the GL, the cell density of OMP-positive OSNs in the
sensory organ and OSN innervation to the OB of CMV-infected
mice are similar to CTLs. This finding supports previous obser-
vations that peripheral infection with neurotropic viruses such as
Bunyavirus leads to specific brain neuroinvasion via OB capillar-
ies, but not through OSN axons (Winkler et al., 2015). Neverthe-
less, we cannot exclude the possibility that in utero infected OSNs
spread the virus to the brain. OSNs have the unique characteristic
to undergo continuous replacement throughout life (Graziadei
and Monti Graziadei, 1983). This ability, observed in all verte-
brates, might allow a complete recovery of OSN inputs following
viral insult in the neonate.
Although OSN inputs and mitral cell population seem to be
spared by CMV, we found that congenital viral infection differ-
entially affect the cell layers and neuron populations of the OB.
The reduced TH expression, CB expression, and maybe reduced
glomerulus size are consistent with significant reductions in
physiological OSN input to the bulb, even if the OSN projection
morphology is unchanged (Stone et al., 1990; Philpot et al., 1997;
Kass et al., 2013). It is possible that the increased apoptosis in the
OB and the reduced neurogenesis in the SVZ may affect the OB
cell number, thus providing a mechanism for olfactory loss. CB-
and TH-positive cells are primarily inhibitory and modulate
neuronal function. Their cell number reduction could underlie
olfactory changes. Later, at W16, only the depletion of the dopa-
minergic cell population in OB glomeruli persisted in our model,
suggesting a higher vulnerability of these cells. Dopaminergic
neurons play a key role in olfactory detection of social and non-
social odorants and their damage leads to a dramatic olfactory
deficit (Lazarini et al., 2014). Because the peak of dopaminergic
cell recruitment in the rodent OB occurs in early postnatal life
(De Marchis et al., 2007, during maximum brain growth (Semple
et al., 2013), it is probable that bulbar dopaminergic neurons are
affected during this time window by congenital CMV infection.
Our study provides the first evidence that congenital CMV
can impair both hearing and olfaction. A recent epidemiological
study reported a remarkable correlation between hearing loss and
olfactory dysfunction in the Korean population after adjustment
for age and sex, but did not study infection as an influential factor
(Park et al., 2017). Other studies in rodents have shown neuro-
invasion in the olfactory system after CMV infection, but did not
assess olfactory behavior (Farrell et al., 2016). Early detection of
olfactory deficits might be relevant to anticipate reduced food
intake and loss of social olfactory cues important to maintain a
strong parent–infant bound (Engen and Lipsitt, 1965; Lemasson
et al., 2005; Harding et al., 2017). Further, we reveal that smell
alteration precedes hearing deterioration at least in the mouse
model. In congenital human CMV infection, hearing loss may
occur several years after birth and can be progressive. Identifica-
tion of children susceptible to hearing impairment is of major
interest because early treatment and use of a hearing aid may
minimize the impact of this deficit on cognitive development.
Despite differences in neurogenesis and sensory development be-
tween human and mouse (Lui et al., 2014; Clark-Gambelunghe
and Clark, 2015), our preclinical findings provide experimental
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support for clinical trials in congenital CMV infection. Assessing
olfaction could lead to novel strategies to monitor this infec-
tion, including long-term neurological outcomes. Future
studies of structural changes in the OB circuit and the func-
tionality of interneuron populations could yield relevant
translational results for follow-up of these infections.
References
Almishaal AA, Mathur PD, Hillas E, Chen L, Zhang A, Yang J, Wang Y,
Yokoyama WM, Firpo MA, Park AH (2017) Natural killer cells attenu-
ate cytomegalovirus-induced hearing loss in mice. PLoS Pathog 13:
e1006599. CrossRef Medline
Alonso M, Lepousez G, Sebastien W, Bardy C, Gabellec MM, Torquet N,
Lledo PM (2012) Activation of adult-born neurons facilitates learning
and memory. Nat Neurosci 15:897–904. CrossRef Medline
Bradford RD, Yoo YG, Golemac M, Pugel EP, Jonjic S, Britt WJ (2015)
Murine CMV-induced hearing loss is associated with inner ear inflamma-
tion and loss of spiral ganglia neurons. PLoS Pathog 11:e1004774.
CrossRef Medline
Bradley RM, Mistretta CM (1975) Fetal sensory receptors. Physiol Rev 55:
352–382. Medline
Branchi I, Santucci D, Vitale A, Alleva E (1998) Ultrasonic vocalizations by
infant laboratory mice: a preliminary spectrographic characterization un-
der different conditions. Dev Psychobiol 33:249 –256. CrossRef Medline
Brizic´ I, Hirsˇl L, Britt WJ, Krmpotic´ A, Jonjic´ S (2017) Immune responses
to congenital cytomegalovirus infection. Microbes Infect. Advance
online publication. Retrieved December 26, 2017. doi: 10.1016/
j.micinf.2017.12.010.
Cekinovic´ D, Golemac M, Pugel EP, Tomac J, Cicin-Sain L, Slavuljica I,
Bradford R, Misch S, Winkler TH, Mach M, Britt WJ, Jonjic´ S (2008)
Passive immunization reduces murine cytomegalovirus-induced brain
pathology in newborn mice. J Virol 82:12172–12180. CrossRef Medline
Chaumorcel M, Souque`re S, Pierron G, Codogno P, Esclatine A (2008) Hu-
man cytomegalovirus controls a new autophagy-dependent cellular anti-
viral defense mechanism. Autophagy 4:46 –53. CrossRef Medline
Clark-Gambelunghe MB, Clark DA (2015) Sensory development. Pediatr
Clin North Am 62:367–384. CrossRef Medline
Cloarec R, Bauer S, Luche H, Buhler E, Pallesi-Pocachard E, Salmi M, Cour-
tens S, Massacrier A, Grenot P, Teissier N, Watrin F, Schaller F, Adle-
Biassette H, Gressens P, Malissen M, Stamminger T, Streblow DN,
Bruneau N, Szepetowski P (2016) Cytomegalovirus infection of the rat
developing brain in utero prominently targets immune cells and pro-
motes early microglial activation. PLoS One 11:e0160176. CrossRef
Medline
Cloe¨tta D, Thomanetz V, Baranek C, Lustenberger RM, Lin S, Oliveri F,
Atanasoski S, Ru¨egg MA (2013) Inactivation of mTORC1 in the devel-
oping brain causes microcephaly and affects gliogenesis. J Neurosci 33:
7799 –7810. CrossRef Medline
Coyne CB, Lazear HM (2016) Zika virus: reigniting the TORCH. Nat Rev
Microbiol 14:707–715. CrossRef Medline
de Chaumont F, Dallongeville S, Chenouard N, Herve´ N, Pop S, Provoost T,
Meas-Yedid V, Pankajakshan P, Lecomte T, Le Montagner Y, Lagache T,
Dufour A, Olivo-Marin JC (2012) Icy: an open bioimage informatics
platform for extended reproducible research. Nat Methods 9:690 –966.
CrossRef Medline
De Marchis S, Bovetti S, Carletti B, Hsieh YC, Garzotto D, Peretto P, Fasolo A,
Puche AC, Rossi F (2007) Generation of distinct types of periglomerular
olfactory bulb interneurons during development and in adult mice: im-
plication for intrinsic properties of the subventricular zone progenitor
population. J Neurosci 27:657– 664. CrossRef Medline
Denizet M, Cotter L, Lledo PM, Lazarini F (2017) Sensory deprivation in-
creases phagocytosis of adult-born neurons by activated microglia in the
olfactory bulb. Brain Behav Immun 60:38 – 43. CrossRef Medline
Deretic V, Saitoh T, Akira S (2013) Autophagy in infection, inflammation
and immunity. Nat Rev Immunol 13:722–737. CrossRef Medline
Engen Y, Lipsitt LP (1965) Decrement and recovery of responses to olfac-
tory stimuli in the human neonate. J Comp Physiol Psychol 59:312–316.
CrossRef Medline
Farrell HE, Lawler C, Tan CS, MacDonald K, Bruce K, Mach M, Davis-
Poynter N, Stevenson PG (2016) Murine cytomegalovirus exploits ol-
faction to enter new hosts. MBio 7:e00251–316. CrossRef Medline
Fornara C, Cassaniti I, Zavattoni M, Furione M, Adzasehoun KMG, De Sil-
vestri A, Comolli G, Baldanti F (2017) Human cytomegalovirus-specific
memory CD4 T-cell response and its correlation with virus transmis-
sion to the fetus in pregnant women with primary infection. Clin Infect
Dis 65:1659 –1665. CrossRef Medline
Forner G, Abate D, Mengoli C, Palu` G, Gussetti N (2015) High cytomega-
lovirus (CMV) DNAemia predicts CMV sequelae in asymptomatic con-
genitally infected newborns born to women with primary infection
during pregnancy. J Infect Dis 212:67–71. CrossRef Medline
Graziadei PP, Monti Graziadei AG (1983) Regeneration in the olfactory sys-
tem of vertebrates. Am J Otolaryngol 4:228 –233. CrossRef Medline
Grelat A, Benoit L, Wagner S, Moigneu C, Lledo PM, Alonso M (2018)
Adult-born neurons boost odor-reward association. Proc Natl Acad Sci
U S A 115:2514 –2519. CrossRef Medline
Han GP, Li L, Kosugi I, Kawasaki H, Tsuchida T, Miura K, Tsutsui Y (2007)
Enhancement of susceptibility of adult mouse brain to cytomegalovirus
infection by infusion of epidermal growth factor. J Neurosci Res 85:2981–
2990. CrossRef Medline
Harding JE, Cormack BE, Alexander T, Alsweiler JM, Bloomfield FH (2017)
Advances in nutrition of the newborn infant. Lancet 389:1660 –1668.
CrossRef Medline
Hasegawa-Ishii S, Shimada A, Imamura F (2017) Lipopolysaccharide-
initiated persistent rhinitis causes gliosis and synaptic loss in the olfactory
bulb. Sci Rep 7:11605. CrossRef Medline
Ibanez CE, Schrier R, Ghazal P, Wiley C, Nelson JA (1991) Human cyto-
megalovirus productively infects primary differentiated macrophages.
J Virol 65:6581– 6588. Medline
Jackson JW, Sparer T (2018) There is always another way! Cytomegalovirus’
multifaceted dissemination schemes. Viruses 10:E383. CrossRef Medline
Juanjuan C, Yan F, Li C, Haizhi L, Ling W, Xinrong W, Juan X, Tao L, Zongzhi
Y, Suhua C (2011) Murine model for congenital CMV infection and
hearing impairment. Virol J 8:70. CrossRef Medline
Kass MD, Pottackal J, Turkel DJ, McGann JP (2013) Changes in the neural
representation of odorants after olfactory deprivation in the adult mouse
olfactory bulb. Chem Senses 38:77– 89. CrossRef Medline
Kennedy WP, Lewis CP, Stow J, Sobol SE (2016) A critical period in post-
natal neuroplasticity of olfaction: a pediatric tracheostomy model. JAMA
Otolaryngol Head Neck Surg 142:127–131. CrossRef Medline
Khodosevich K, Lazarini F, von Engelhardt J, Kaneko H, Lledo PM, Monyer
H (2013) Connective tissue growth factor regulates interneuron survival
and information processing in the olfactory bulb. Neuron 79:1136 –1151.
CrossRef Medline
Kobayakawa K, Kobayakawa R, Matsumoto H, Oka Y, Imai T, Ikawa M,
Okabe M, Ikeda T, Itohara S, Kikusui T, Mori K, Sakano H (2007) In-
nate versus learned odour processing in the mouse olfactory bulb. Nature
450:503–508. CrossRef Medline
Koontz T, Bralic M, Tomac J, Pernjak-Pugel E, Bantug G, Jonjic S, Britt WJ
(2008) Altered development of the brain after focal herpesvirus infection
of the central nervous system. J Exp Med 205:423– 435. CrossRef Medline
Kosmac K, Bantug GR, Pugel EP, Cekinovic D, Jonjic S, Britt WJ (2013)
Glucocorticoid treatment of MCMV infected newborn mice attenuates
CNS inflammation and limits deficits in cerebellar development. PLoS
Pathog 9:e1003200. CrossRef Medline
Kosugi I, Shinmura Y, Li RY, Aiba-Masago S, Baba S, Miura K, Tsutsui Y
(1998) Murine cytomegalovirus induces apoptosis in non-infected cells
of the developing mouse brain and blocks apoptosis in primary neuronal
culture. Acta Neuropathol 96:239 –247. CrossRef Medline
Lazarini F, Gabellec MM, Torquet N, Lledo PM (2012) Early activation of
microglia triggers long-lasting impairment of adult neurogenesis in the
olfactory bulb. J Neurosci 32:3652–3664. CrossRef Medline
Lazarini F, Gabellec MM, Moigneu C, de Chaumont F, Olivo-Marin JC, Lledo
PM (2014) Adult neurogenesis restores dopaminergic neuronal loss in
the olfactory bulb. J Neurosci 34:14430 –14442. CrossRef Medline
Lemasson M, Delbe´ C, Gheusi G, Vincent JD, Lledo PM (2005) Use of ul-
trasonic vocalizations to assess olfactory detection in mouse pups treated
with 3-methylindole. Behav Processes 68:13–23. CrossRef Medline
Levine B, Mizushima N, Virgin HW (2011) Autophagy in immunity and
inflammation. Nature 469:323–335. CrossRef Medline
Li RY, Tsutsui Y (2000) Growth retardation and microcephaly induced in
mice by placental infection with murine cytomegalovirus. Teratology 62:
79 – 85. CrossRef Medline
Lledo PM, Alonso M, Grubb MS (2006) Adult neurogenesis and functional
10436 • J. Neurosci., December 5, 2018 • 38(49):10424–10437 Lazarini et al. • Early Olfactory Deficits in Congenital CMV Infection
plasticity in neuronal circuits. Nat Rev Neurosci 7:179 –193. CrossRef
Medline
Lui JH, Nowakowski TJ, Pollen AA, Javaherian A, Kriegstein AR, Oldham MC
(2014) Radial glia require PDGFD-PDGFR signalling in human but not
mouse neocortex. Nature 515:264 –268. CrossRef Medline
Maiuri MC, Zalckvar E, Kimchi A, Kroemer G (2007) Self-eating and self-
killing: crosstalk between autophagy and apoptosis. Nat Rev Mol Cell Biol
8:741–752. CrossRef Medline
Manicklal S, Emery VC, Lazzarotto T, Boppana SB, Gupta RK (2013) The
“silent” global burden of congenital cytomegalovirus. Clin Microbiol Rev
26:86 –102. CrossRef Medline
McFarlane S, Aitken J, Sutherland JS, Nicholl MJ, Preston VG, Preston CM
(2011) Early induction of autophagy in human fibroblasts after infection
with human cytomegalovirus or herpes simplex virus 1. J Virol 85:4212–
4221. CrossRef Medline
Monath TP, Cropp CB, Harrison AK (1983) Mode of entry of a neurotropic
arbovirus into the central nervous system: reinvestigation of an old con-
troversy. Lab Invest 48:399 – 410. Medline
Muller WJ, Jones CA, Koelle DM (2010) Immunobiology of herpes simplex
virus and cytomegalovirus infections of the fetus and newborn. Curr
Immunol Rev 6:38 –55. CrossRef Medline
Mutnal MB, Cheeran MC, Hu S, Lokensgard JR (2011) Murine cytomega-
lovirus infection of neural stem cells alters neurogenesis in the developing
brain. PLoS One 6:e16211. CrossRef Medline
Mizushima N, Levine B (2010) Autophagy in mammalian development and
differentiation. Nat Cell Biol 12:823– 830. CrossRef Medline
Nakatogawa H, Suzuki K, Kamada Y, Ohsumi Y (2009) Dynamics and di-
versity in autophagy mechanisms: lessons from yeast. Nat Rev Mol Cell
Biol 10:458 – 467. CrossRef Medline
Nguyen Y, Couloigner V, Rudic M, Nguyen Y, Couloigner V, Rudic M,
Grayeli AB, Ferrary E, Sterkers O (2009) An animal model of cochlear
implantation with an intracochlear fluid delivery system. Acta Otolaryn-
gol 129:1153–1159. CrossRef Medline
Odeberg J, Wolmer N, Falci S, Westgren M, Seiger A, So¨derberg-Naucle´r C
(2006) Human cytomegalovirus inhibits neuronal differentiation and
induces apoptosis in human neural precursor cells. J Virol 80:8929 – 8939.
CrossRef Medline
Oliver KR, Scallan MF, Dyson H, Fazakerley JK (1997) Susceptibility to a
neurotropic virus and its changing distribution in the developing brain is
a function of CNS maturity. J Neurovirol 3:38 – 48. CrossRef Medline
Park JH, Byeon HK, Park KN, Kim JW, Lee SW, Han KD, Chang JW, Kim WS,
Koh YW, Ban MJ (2017) Epidemiological association of olfactory dys-
function with hearing loss and dysphonia in the Korean population: a
cross-sectional study. Medicine (Baltimore) 96:e8890. CrossRef Medline
Pereira L, Maidji E (2008) Cytomegalovirus infection in the human pla-
centa: maternal immunity and developmentally regulated receptors on
trophoblasts converge. Curr Top Microbiol Immunol 325:383–395.
Medline
Philpot BD, Lim JH, Brunjes PC (1997) Activity-dependent regulation of
calcium-binding proteins in the developing rat olfactory bulb. J Comp
Neurol 387:12–26. CrossRef Medline
Rawlinson WD, Farrell HE, Barrell BG (1996) Analysis of the complete
DNA sequence of murine cytomegalovirus. J Virol 70:8833– 8849.
Medline
Reshef R, Kudryavitskaya E, Shani-Narkiss H, Isaacson B, Rimmerman N,
Mizrahi A, Yirmiya R (2017) The role of microglia and their CX3CR1
signaling in adult neurogenesis in the olfactory bulb. Elife 6: e30809.
CrossRef Medline
Sakao-Suzuki M, Kawasaki H, Akamatsu T, Meguro S, Miyajima H, Iwashita
T, Tsutsui Y, Inoue N, Kosugi I (2014) Aberrant fetal macrophage/mi-
croglial reactions to cytomegalovirus infection. Ann Clin Transl Neurol
1:570 –588. CrossRef Medline
Sarnat HB (1978) Olfactory reflexes in the newborn infant. J Pediatr 92:
624 – 626. Medline
Sarnat HB, Yu W (2016) Maturation and dysgenesis of the human olfactory
bulb. Brain Pathol 26:301–318. CrossRef Medline
Schaal B, Marlier L, Soussignan R (1998) Olfactory function in the human
fetus: evidence from selective neonatal responsiveness to the odor of am-
niotic fluid. Behav Neurosci 112:1438 –1449. CrossRef Medline
Schaal B, Marlier L, Soussignan R (2000) Human foetuses learn odours
from their pregnant mother’s diet. Chem Senses 25:729 –737. CrossRef
Medline
Schachtele SJ, Mutnal MB, Schleiss MR, Lokensgard JR (2011) Cyto-
megalovirus-induced sensorineural hearing loss with persistent cochlear
inflammation in neonatal mice. J Neurovirol 17:201–211. CrossRef
Medline
Schultz KL, Vernon PS, Griffin DE (2015) Differentiation of neurons re-
stricts arbovirus replication and increases expression of the alpha isoform
of IRF-7. J Virol 89:48 – 60. CrossRef Medline
Scimemi P, Santarelli R, Selmo A, Mammano F (2014) Auditory brainstem
responses to clicks and tone bursts in C57BL/6J mice. Acta Otorhinolar-
yngol Ital 34:264 –271. Medline
Semple BD, Blomgren K, Gimlin K, Ferriero DM, Noble-Haeusslein LJ
(2013) Brain development in rodents and humans: identifying bench-
marks of maturation and vulnerability to injury across species. Prog Neu-
robiol 106 –107:1–16. CrossRef Medline
Seo Y, Kim HS, Kang I, Choi SW, Shin TH, Shin JH, Lee BC, Lee JY, Kim JJ,
Kook MG, Kang KS (2016) Cathepsin S contributes to microglia-
mediated olfactory dysfunction through the regulation of Cx3cl1-Cx3cr1
axis in a Niemann-Pick disease type C1 model. Glia 64:2291–2305.
CrossRef Medline
Siopi E, Denizet M, Gabellec MM, de Chaumont F, Olivo-Marin JC, Guilloux
JP, Lledo PM, Lazarini F (2016) Anxiety- and depression-like states lead
to pronounced olfactory deficits and impaired adult neurogenesis in
mice. J Neurosci 36:518 –531. CrossRef Medline
Stone DM, Wessel T, Joh TH, Baker H (1990) Decrease in tyrosine hydrox-
ylase, but not aromatic L-amino acid decarboxylase, messenger RNA in
rat olfactory bulb following neonatal, unilateral odor deprivation. Brain
Res Mol Brain Res 8:291–300. CrossRef Medline
Teissier N, Delezoide AL, Mas AE, Khung-Savatovsky S, Bessie`res B, Nardelli
J, Vauloup-Fellous C, Picone O, Houhou N, Oury JF, Van Den Abbeele T,
Gressens P, Adle-Biassette H (2011) Inner ear lesions in congenital cy-
tomegalovirus infection of human fetuses. Acta Neuropathol 122:763–
774. CrossRef Medline
Teissier N, Fallet-Bianco C, Delezoide AL, Laquerrie`re A, Marcorelles P,
Khung-Savatovsky S, Nardelli J, Cipriani S, Csaba Z, Picone O, Golden JA,
Van Den Abbeele T, Gressens P, Adle-Biassette H (2014) Cyto-
megalovirus-induced brain malformations in fetuses. J Neuropathol Exp
Neurol 73:143–158. CrossRef Medline
Tian J, Pinto JM, Cui X, Zhang H, Li L, Liu Y, Wu C, Wei Y (2016) Sendai
virus induces persistent olfactory dysfunction in a murine model of
PVOD via effects on apoptosis, cell proliferation, and response to odor-
ants. PLoS One 11:e0159033. CrossRef Medline
Townsend CL, Forsgren M, Ahlfors K, Ivarsson SA, Tookey PA, Peckham CS
(2013) Long-term outcomes of congenital cytomegalovirus infection in
sweden and the united kingdom. Clin Infect Dis 56:1232–1239. CrossRef
Medline
Tsutsui Y (2009) Effects of cytomegalovirus infection on embryogenesis
and brain development. Congenit Anom (Kyoto) 49:47–55. CrossRef
Medline
van Den Pol AN, Mocarski E, Saederup N, Vieira J, Meier TJ (1999) Cyto-
megalovirus cell tropism, replication, and gene transfer in brain. J Neu-
rosci 19:10948 –10965. CrossRef Medline
Watt AP, Loughlin L, Coyle PV (2016) Congenital CMV disease: a female
bias in northern Ireland? J Clin Virol 77:99 –100. CrossRef Medline
Wheeler DL, Athmer J, Meyerholz DK, Perlman S (2017) Murine olfactory
bulb interneurons survive infection with a neurotropic coronavirus.
J Virol pii: JVI.01099-17. CrossRef Medline
Whitman MC, Greer CA (2009) Adult neurogenesis and the olfactory sys-
tem. Prog Neurobiol 89:162–175. CrossRef Medline
Williamson WD, Demmler GJ, Percy AK, Catlin FI (1992) Progressive hear-
ing loss in infants with asymptomatic congenital cytomegalovirus infec-
tion. Pediatrics 90:862– 866. Medline
Winkler CW, Race B, Phillips K, Peterson KE (2015) Capillaries in the ol-
factory bulb but not the cortex are highly susceptible to virus-induced
vascular leak and promote viral neuroinvasion. Acta Neuropathol 130:
233–245. CrossRef Medline
Lazarini et al. • Early Olfactory Deficits in Congenital CMV Infection J. Neurosci., December 5, 2018 • 38(49):10424–10437 • 10437
